Antifungal agents, polyenes, and azoles are available for the treatment of serious and life-threatening fungal infection, mainly caused by Candida albicans and Aspergillus fumigatus. However, their clinical uses are restricted due to toxicity (polyenes), fungistatic activity (azoles), and the emergence of resistant isolates (azoles). 1, 2) To overcome these problems, novel antifungal agents with a different mode of action are in demand.
1,3-b-D-Glucan synthase (UDP-glucose: 1,3-b-D-glucan 3-b-D-glucosyltransferase; EC 2.4.1.34), catalyses the synthesis of 1,3-b-D-glucan, the most abundant component of the fungal cell wall. 1,3-b-D-Glucan synthase is composed of a putative catalytic subunit with sixteen putative transmembrane domains encoded by a pair of closely related genes, FKS1/GSC1/CWH53/ETG1/CND1/PBR1/YLR342W and FKS2/GSC2/G4074/YGRO32W, [3] [4] [5] [6] [7] [8] and a regulatory subunit encoded by the RHO1 9, 10) in Saccharomyces cerevisiae. In C. albicans, the catalytic and regulatory subunits are encoded by CaFKS1/GSC1, 11, 12) and CaRHO1, 13) respectively. 1,3-b-D-Glucan synthase has three features of a promising target for an antifungal agent: 2, 14, 15) 1) its function is essential for growth, proven by the fact that the disruption of the genes for the catalytic subunit of 1,3-b-D-glucan synthase is a lethal event in S. cerevisiae, 6, 8) C. albicans, 11, 12) and Cryptococcus neoformans 16) ; 2) mammalian cells have no comparable cell wall, indicating that a 1,3-b-D-glucan synthase inhibitor would be highly selective to fungal cells; and 3) genes for catalytic subunits have been identified from several pathogenic fungi, such as C. albicans, 11, 12) Cr. neoformans, 16) A. fumigatus, 17) and Paracoccidioides brasiliensis, 18) and are highly homologous to each other. It is likely that 1,3-b-D-glucan synthase inhibitors might possess a broad spectrum of antifungal activity.
Several 1,3-b-D-glucan synthase inhibitors have been identified, such as echinocandins and papulacandins. 19, 20) Papulacandins are liposaccharide inhibitors isolated from Papularia sphaerosperma. The echinocandins, including cilofungin, aculeacins, and pneumocandins, are cyclic hexapeptides with a lipophilic side chain such as a linoleoyl or myristoyl moiety. From this chemical class, caspofungin and micafungin have been launched recently, and anidulafungin is being developed. Aerothricin3/FR901469, a cyclic lipopeptidelactone composed of twelve amino acids and a 3Ј-hydroxypalmitoyl moiety, is another class of lipopeptide inhibitors recently isolated. [21] [22] [23] [24] More recently, another class of inhibitors, terpene glycosides, have been identified from natural sources. 25, 26) We describe here a novel piperazine propanol derivative of 1,3-b-D-glucan synthase inhibitor identified from a chemical library. In vitro antifungal activity of this inhibitor was assessed. Susceptibility analysis of S. cerevisiae fks temperature-sensitive mutants supports the conclusion that the piperazine propanol derivative inhibits fungal cell growth by inhibiting fungal 1,3-b-D-glucan synthase.
MATERIALS AND METHODS

Fungal Strains
As reference strains, ATCC strains from the American Type Culture Collection (Rockville, MD, U.S.A.) and IFO strains from the Institute for Fermentation Osaka (Osaka, Japan) were purchased. Other clinical isolates were obtained from hospitals in Japan. The S. cerevisiae strains used in this study are listed in Table 1 and were cultivated in YPD medium (2% Bacto peptone, 1% Bacto yeast extract, and 2% glucose). The YOC1071, YOC1077, YOC1081, YOC1085, and YOC1089 have the same FKS1 alleles as YOC1072, YOC1078, YOC1082, YOC1086, and YOC1090, 27) respectively. Construction of the temperaturesensitive (ts) strains and a wild-type FKS1 control YOC1001 in the Dfks1 Dfks2 background 28) will be described elsewhere (M. Abe, M. Minemura-Asakawa, T. Utsugi, M. SekiyaKawasaki, A. Hirata, H. Qadota, K. Morishita, T. Watanabe, and Y. Ohya, unpublished results).
Chemicals The chemical library of compounds was obtained from Alanex Corp. (CA, U.S.A.). Amphotericin B (AMB) and cycloheximide were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Aerothricin3 was prepared as previously described. 29) GSI578 [(2,6-Difluoro-phenyl)-carbamic acid 3-(4-benzothiazol-2-yl-piperazine-1-yl)-propyl ester] was synthesized as follows. To a solution of 2-chloro-benzothiazole in toluene, piperazine and diisopropylethylamine were added. The reaction mixture was stirred at 120°C for 18 h, then added water and extracted with dichloromethane. The organic phase was dried with magnesium sulfate and concentrated under vacuum. Recrystallization from dichloromethane and hexane gave 2-piperazine-1-yl-benzothiazole. To a solution of 2-piperazine-1-yl-benzothiazole in toluene, 3-bromo-propan-1-ol and diisopropylethylamine were added. The reaction mixture was stirred at 120°C for 2 h, then added water and extracted with dichloromethane. The organic phase was dried with magnesium sulfate and concentrated under vacuum. The crude material was purified by column chromatography with 2-5% methanol in dichloromethane and recrystallized from dichloromethane and hexane to afford 3-(4-benzo-thiazol-2-yl-piperazine-1-yl)-propan-1-ol. To a solution of 3-(4-benzo-thiazol-2-ylpiperazine-1-yl)-propan-1-ol in tetrahydrofuran, 1,3-difluoro-2-isocyanato-benzene and catalytic amount of pyridine were added. The reaction mixture was stirred at 70°C for 1 h then concentrated under vacuum. The crude material was purified by column chromatography (2% methanol in dichloromethane) to afford (2,6-difluoro-phenyl)-carbamic acid 3-(4-benzothiazol-2-yl-piperazine-1-yl)-propyl ester.
Purification of 1,3-b b-D-Glucan Synthase and Measurement of Its Inhibition Membrane preparation and partial purification of 1,3-b-D-glucan synthase were described previously.
11,13) 1,3-b-D-Glucan synthase activity measurement was performed as previously described.
3) Briefly, the membrane fraction was prepared from late-log phase cells and then the enzyme was partially purified by product entrapment. The partially purified enzyme was mixed with 0.1 mM UDP- [6- 3 H]-glucose (222 Bq, Amersham), 75 mM Tris-Cl pH 7.5, 0.75 mM EDTA, 25 mM KF, 20 mM guanosine-5Ј-(gthio)-triphosphate, 0.1% BSA, and 7.8% Glycerol. Test compounds were serially diluted and added. The reaction was carried out in 100 ml at 25°C for 30 min. After filtration and twice washing with 70% ethanol, the radiolabeled glucose incorporated into the polymerized glucan on the filter was quantified by measuring the radioactivity.
In Vitro Antifungal Activity Antifungal susceptibility assay was performed by the NCCLS M27-A2 microdilution method using modified media: Yeast Nitrogen Base (YNB) supplemented with 1% glucose and 0.25% K 2 HPO 4 was used for the Candida spp. and, when solidified with 0.2% lowmelting temperature agarose, used for A. fumigatus. The inoculum size for all strains was 1 to 3ϫ10 4 conidia/ml in final concentration. 96-well plates were incubated at 35°C for 1 d for C. albicans and A. fumigatus, 2 d for C. glabrata ATCC2001, and 3 d for IFO0005. MICs were determined by the concentration of drug that produced an 80% reduction of turbidity compared to that of the drug free control measured by spectrophotometer at an optical density of 600 nm. The susceptibility of S. cerevisiae strains was measured the same, except for temperatures of 25°C for null mutants and 25°C, 31°C, 32°C, and 33°C for ts mutants. IC 50 values refer to the compound concentrations that gave 50% inhibition of cell growth compared with the control.
RESULTS AND DISCUSSION
In order to identify novel chemical classes of antifungals, screening of a chemical library was conducted by monitoring the inhibition of 1,3-b-D-glucan synthase activity. 1,3-b-DGlucan synthase was partially purified by product entrapment from the pathogenic fungus C. albicans IFO1060. 11, 13) We identified GSI578 [(2,6-Difluoro-phenyl)-carbamic acid 3-(4-benzothiazol-2-yl-piperazine-1-yl)-propyl ester] as a potent 1,3-b-D-glucan synthase inhibitor (Fig. 1) . The IC 50 value of GSI578 against 1,3-b-D-glucan synthase was 0.16 mM, whereas that of aerothricin3 was 0.012 mM.
The inhibitory activity of GSI578 against the growth of various fungal strains was compared to caspofungin, aerothricin3, and amphotericin B (Table 2 ). GSI578 exhibited antifungal activity against C. albicans, C. glabrata, and A. fumigatus comparative to the reference antifungals.
To explore the inhibition of 1,3-b-D-glucan synthesis by the piperazine propanol derivative, we measured the susceptibility of fks1 ts mutants in the Dfks2 background at semipermissive and permissive temperatures. Figure 2 shows that ts mutants exhibited hypersensitive phenotype to GSI578 in a temperature dependent manner, as well as to known 1,3-b-Dglucan synthase inhibitor aerothricin3. The control drug cycloheximide, which targets protein synthesis, inhibits independently of the temperature. These results indicated that piperazine propanol derivative GSI578 inhibits fungal cell growth by inhibiting fungal 1,3-b-D-glucan synthase.
We further explored the effect of the piperazine propanol derivative on 1,3-b-D-glucan synthesis. The Dfks1 mutant is known to be hypersensitive to aerothricin3 and L-733560, a close analogue of caspofungin, compared to Dfks2 and their parental strain A451. 8, 29) Therefore, the susceptibility of FKS deletion mutants of S. cerevisiae to piperazine propanol GSI578 was measured. Interestingly, GSI578 exhibited similar inhibitory activity to Dfks1, Dfks2, and their parental strain (Table 3) The growth of fungi was measured by absorbance at 600 nm. The yeast growth was measured by absorbance at 600 nm. Values are the averages of three independent experiments and standard deviations. 
